Aviator’s Breathing Oxygen (ABO) Supply and Delivery

The contract entails the recurring supply and delivery of gaseous and liquid medical oxygen specifically formulated for aviator use across U.S. military installations, ensuring full compliance with military specifications for breathing oxygen. The product, known as Aviator’s Breathing Oxygen (ABO), is critical for sustaining pilot performance at high altitudes and must meet stringent purity and pressure standards to guarantee safety and operational readiness. The oxygen will be delivered in both liquid and gaseous forms, with logistics arranged to support continuous availability at designated military locations without interruption. This is a subcontract awarded under the Defense Logistics Agency, which operates under the Department of Defense, and falls under the NAICS code for pharmaceutical and medicine manufacturing. The contract is scheduled to be active from June 26, 2026, and encompasses ongoing fulfillment needs essential to air operations. Delivery terms are structured to align with military timelines and storage protocols, ensuring the oxygen remains viable and immediately accessible for emergency and routine flight missions. While the exact delivery locations and quantities are not specified here, performance is expected to be consistent with federal defense supply chain requirements and quality control benchmarks.